Discover how groundbreaking research on unique immune cells and advanced AI tools offers renewed hope for improving cancer ...

Patients with AML aged 80 years and older face poor survival despite treatment advances, highlighting the need for improved, ...

Dana-Farber researchers identified factors predicting the success of donor lymphocyte infusion (DLI) in treating relapsed AML ...

A 7-year-old in Idaho is at the forefront of many minds in the Lewisville area, as her family and community plan a fundraiser ...

The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

Initial data from the Phase 1 trial expected in 2025SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the ...

AmMax Bio, Inc. ("AmMax”), a private clinical-stage biopharmaceutical company developing innovative therapeutics in oncology, ...

StockNews.com initiated coverage on shares of MEI Pharma (NASDAQ:MEIP – Free Report) in a research report released on Sunday. The firm issued a buy rating on the stock. MEI Pharma Price Performance ...

The ACS has released cancer statistics for 2025 suggesting that more than 2 million new cases of cancer will be diagnosed in the US this year.

Researchers at the University of Colorado Anschutz Medical Campus found a promising therapeutic candidate that could aid in ...

Whether you’re a fan of the All Blacks, a follower of the women’s game or someone who watches every phase of play in the Premiership, our rugby features and news pieces will provide you with all of ...